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Objective: Catheter-associated upper extremity deep venous thrombosis (CAUEDVT) is well known; however, resolution
rates and factors affecting resolution of CAUEDVT are not well characterized. This study determined resolution rates
and factors associated with resolution of CAUEDVT.
Methods: From January 1, 2002, to June 30, 2006, 1761 upper extremity venous duplex ultrasound (DU) studies were
performed, and a new UEDVT was found in 253 (14.4%). Of these, 150 patients had routine follow-up and 101 had
CAUEDVT. Demographics, follow-up DU results, and risk factors for venous thrombosis were recorded in the patients
with follow-up studies and CAUEDVT. Univariate analysis and multivariate logistic regression analysis was performed
to determine independent risk factors for complete thrombus resolution.
Results: There were 49 men (49%) and 52 women (51%) with CAUEDVT and follow-up studies. Mean age was 49 years
(range, 5 months-80 years). Patients with CAUEDVT had risk factors for venous thrombosis that included malignancy
in 34%, recent surgery/trauma in 34%, known hypercoagulable state in 11%, concomitant lower extremity DVT in 21%,
and pulmonary embolism in 5%. Complete resolution of DVT on follow-up was documented in 46%. Thrombosis
resolved in only 25% (6 of 24) when the catheter was not removed (P < .05). Anticoagulation did not improve the rate
of thrombus resolution (P < 1.0) compared with catheter removal alone. Of the patients who had thrombus resolution,
75% resolved by 100 days (range, 1-914 days) after catheter removal <48 hours of diagnosis. In multivariate analysis,
only catheter removal predicted the likelihood of thrombus resolution (odds ratio, 3.25; 95% confidence interval,
1.16-9.09; P .025). New-site UEDVT developed in 86% of patients with CAUEDVTwho underwent catheter removal
and immediate catheter placement in a new site. Pulmonary embolism developed in five patients with CAUEDVT. Of
these, three had documented lower extremity DVT as well. No pulmonary emboli were fatal.
Conclusions: More than half of CAUEDVT resolve <113 days when the catheter is removed <48 hours of diagnosis.
New-site catheter placement has a high rate of new associated UEDVT. Anticoagulation does not appear to augment
resolution of UEDVT. (J Vasc Surg 2010;51:108-13.)Upper extremity deep venous thrombosis (UEDVT)
occurs in 0.15% of hospitalized patients.1 Indwelling cen-
tral venous catheters have been reported to be a strong
independent risk factor for UEDVT.2 In one retrospective
study of patients with duplex ultrasound (DU)-proven
UEDVT, central venous catheters were present in 110 of
170 (65%) with UEDVT.3 This study also documented a
7% risk of pulmonary embolism (PE). Mortality in this
patient population, although not directly attributed to the
central venous catheters, was high, at 16% at 1 month and
34% at 3 months. Another study by the same authors
evaluated 2451 upper extremity venous DU examinations
and found 598 were positive for UEDVT, of which 307
were associated with a central venous catheter. PE occurred
in 33 (5%), and mortality at 2 months was 29%.4
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108Although central venous catheters clearly are a signifi-
cant risk factor for UEDVT, little is currently known about
the factors affecting resolution of catheter-associated
UEDVT (CAUEDVT). Specifically, we do not know the
effect of catheter removal or anticoagulation on resolution
of CAUEDVT. The current study was undertaken to fur-
ther characterize the natural history of CAUEDVT and to
identify factors that may be associated with thrombus res-
olution.
PATIENTS AND METHODS
From January 1, 2002, to June 30, 2006, symptomatic
patients undergoing DU imaging of the upper extremities
were identified from a database of all vascular laboratory
studies performed at Oregon Health and Science Univer-
sity (Portland, Ore). Most symptoms were swelling or pain,
or both, in upper extremities. According to the protocol,
patients were examined supine with the head turned oppo-
site to the extremity under examination. Except when
impeded by the presence of bandages or fixation devices,
named superficial and deep upper extremity veins were
examined, including the internal jugular, subclavian, axil-
lary, brachial, cephalic, and basilic veins.
DVT was diagnosed by the presence of intraluminal ech-
oes with lack of flow response to augmentation and compres-
sion maneuvers in the internal jugular, subclavian, axillary, or
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mented by the vascular laboratory technician on predesigned
upper extremity worksheets that included the upper extremity
venous anatomy. A distinction between acute and chronic
thrombus was not made unless it was obvious (ie, patient had
previous diagnosis of UEDVT). The criteria used to describe
an acute thrombus were new symptoms and lack of criteria
suggesting chronic thrombus (ie, echogenic veins).
Patients with CAUEDVT diagnosed by DU imaging
and who had had at least one follow-up DU examination
were selected for this study. UEDVT was considered
catheter-associated if a central catheter was present in the
anatomic location of the UEDVT 30 days from the DU
examination documenting DVT. Partial resolution of
thrombus was defined as recanalization of at least one
venous segment on a follow-up DU study. Complete res-
olution was defined as the absence of venous thrombus on
the last follow-up DU examination.
The electronic medical records were reviewed for doc-
umentation of the central venous catheter. Central venous
catheter placement and the type of catheter were further
confirmed by additional review of all available inpatient and
outpatient progress notes, procedure notes, and radiologic
images and reports. Documented thrombosis risk factors
included inherited and acquired hypercoagulable states,
recent surgery, trauma, or immobilization 30 days, and
cancer. The indication for catheter placement, the type of
catheter placed, and the site of catheter placement were also
recorded. Catheter removal was noted along with when the
catheter was removed and the indication for removal.
Treatment with anticoagulation was documented. Pa-
tients were not considered to be anticoagulated unless they
were given therapeutic doses of heparin or warfarin, or
both. The indication, timing, duration, and therapeutic
levels (international normalized ratios) of anticoagulation
were recorded. Complications of anticoagulation were
noted, along with the presence of lower extremity DVT and
PE. Lower extremity DVT was diagnosed with compres-
sion DU imaging. A diagnosis of PE was made by ventila-
tion/perfusion scan, spiral chest computed tomography
angiography, or by pulmonary angiography. Follow-up
DU studies were classified by whether they showed com-
plete resolution of the initial CAUEDVT.
Statistical analysis was performed using 2 analysis for
continuous variables in a univariate model. Multivariate
logistic regression analysis was used to determine indepen-
dent risk factors for complete thrombus resolution. Odds
ratios (OR) are presented with their 95% confidence inter-
vals (CI). Statistical analysis was completed with SPSS 17.0
software (SPSS Inc, Chicago, Ill).
RESULTS
Upper extremity DVT. During the period reviewed,
1761 upper extremity venous DU scans performed; of
these, 454 (25.7%) were positive for UEDVT, and a new
diagnosis of UEDVT was noted in 253 (14.4%). A total of
226 follow-up examinations were available for 150, repre-
senting 1.51 follow-up studies per patient (range 1-10studies). The average number of follow-up studies for the
patients with CAUEDVTwas 1.76. Follow-up studies were
obtained from 1 day to 7.9 years (2579 days) after the
initial diagnosis of UEDVT (Fig 1). There were 70 men
(47%) and 80 women (53%). The mean age was 47 years
(range, 5 months-99 years).
Catheter-associated UEDVT. Of the 150 patients
with follow-up studies, CAUEDVT was present in 101
(67%), comprising 49men (48.5%) and 52 women (51.5%)
who were a mean age of 49 years (range, 5 months-80
years). Additional risk factors, aside from the central venous
Fig 1. Histogram shows the timing of follow-up studies relative
to the initial diagnosis.
Table I. Factors affecting resolution of catheter-
associated upper extremity deep venous thrombosis in
101 patients
Variable Total Resolved Not resolved P
Patients, No. 101 46 55
Catheter duration, d 123.35 129.44
Sex, No.
Men 49 25 24
Women 52 21 31 .3214
Catheter removed 77 40 37
Catheter removed 48 h 43 24 19 .4962
Catheter not removed 24 6 18 .0334
Anticoagulated 62 24 38 .1021
DVT location
Internal jugular 16 15 .5166
Subclavian 7 3 .1790
Axillary 3 4 .99
Brachial 4 3 .6990
Multilevel 16 30 .0705
Catheter type
Central venous 13 17 .8292
PICC 21 19 .3083
AICD 2 1 .5910
Portacatheter 2 3 .99
Hemodialysis 8 15 .3409
Associated conditions
Cancer 14 20 .6728
Hypercoagulable state 2 9 .624
Lower extremity DVT 10 11 .99
Pulmonary embolism 2 3 .99
AICD, Automatic implantable cardioverter-defibrillator;DVT, deep venous
thrombosis.catheter in the patients with CAUEDVT, included malig-
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and a known hypercoagulable state in 11 (11%). Concom-
itant lower extremity DVTwas present in 21 (21%), and PE
was documented in five (5%; Table I).
Catheter type. Of the 101 instances of CAUEDVT,
there were 30 central venous catheters (average duration,
9.7 days; range, 0-27 days), 40 peripherally inserted central
catheters (PICCs; average duration, 26 days; range, 0-188
days), 3 implantable cardioverter-defibrillators (ICDs; av-
erage duration, 1292 days; range, 486-2886), 5 portacaths
(average duration, 496 days; range, 66-1412), and 23
hemodialysis catheters (average duration, 221.95 days;
range, 1-886 days). Placement for 22 of 23 hemodialysis
catheters was through the internal jugular vein. Resolution
of CAUEDVT occurred in 13 of 30 central venous cathe-
ters (43.33%), 21 of 40 PICCs (52.5%), 2 of 3 ICDs (67%),
2 of 5 portacaths (40%), and 8 of 23 hemodialysis catheters
(34.78%).
Thrombus location. Thrombus was isolated to the
internal jugular vein in 31 patients, subclavian vein in 10,
axillary vein in 7, brachial in 7, and was present in multiple
deep sites in 46. Superficial venous thrombosis was present
at the time of diagnosis in 63 of 101 cases (63%) with
CAUEDVT. By comparison, superficial venous thrombosis
was present at the time of diagnosis in only eight of 49
patients (16%) with non-CAUEDVT.
Thrombus resolution. Of the 101 instances of
CAUEDVT, resolution was documented in 46 (46%) by
the follow-up DU study, and 33 (72%) of these had
resolved by 100 days (range, 1-914 days). Partial resolu-
tion was seen in 21 (21%), no change in 22 (22%), and
progression seen in 12 cases (12%; Table II). Complete
resolution of thrombus occurred in 16 of the 31 cases
(51.6%) of isolated internal jugular thrombus, 7 of 10
(70%) with isolated subclavian vein thrombus, 3 of 7
(42.8%) with isolated axillary vein thrombus, and in 4 of
7 (57.1%) with isolated brachial vein thrombus. There
were no differences in the percentages of complete res-
olution of CAUEDV thrombi with respect to thrombus
location (P  .1790 to .99 for all comparisons). Com-
plete resolution may have been affected by the involve-
ment of the original CAUEDVT with multiple deep
venous segments. Thrombus resolved completely in only
16 of 46 (34.7%) where thrombus involved two or more
anatomic segments (P  .0705). By life-table analysis,
Table II. Duplex ultrasound result by status of central
venous catheter
Result
Removed, No. (%) Not removed, No. (%)
(n  77) (n  24)
Resolved 40 (51.9) 6 (25)
Partial resolution 18 (23.4) 3 (12.5)
No change 14 (18.2) 8 (33.3)
Progression 5 (6.5) 7 (29.2)resolution rates of CAUEDVT are projected from 18.8%at 1 month and increasing to 73.3% at 24 months (Table
III, Fig 2).
Duration of catheter placement. Resolution rates of
CAUEDVT were not affected by the length of time the
catheter was in place before the diagnosis of CAUEDVT.
The average duration of catheter placement was 127 days
(range, 0-2886 days) and was placed 30 days before
diagnosis in 61 of the 101 patients (61%). Thrombus
resolved in 30 (49%) and failed to resolve in 31 (51%). In 21
patients with CAUEDVT, catheters were in place 31 to 90
days before the diagnosis of CAUEDVT, with eight (26%)
resolving. The rate of resolution for CAUEDVT for cath-
eters in place90 days before the diagnosis of CAUEDVT
was 42% (8 of 19; P  .41 to .82 for all comparisons to
catheters in place 30 days).
Catheter removal. Of the 101 catheters, 77 were
removed because of symptoms or after discovery of the
CAUEDVT, and of these, 17 were discontinued before the
initial DU examination but 30 days of the DU study.
Complete resolution of CAUEDVT occurred in 51.9% of
the patients when the catheter was removed. Only six of 24
CAUEDVTs (25%) completely resolved when the catheters
were not removed. The catheter was removed48 hours of
diagnosis in 43 of the 77, including four of 17 in whom the
catheter was removed before the DU examination. Throm-







0-1 18.80 0.039 101
1-3 31.90 0.052 55
3-6 57.00 0.065 32
6-12 62.60 0.068 19
12-24 73.30 0.076 8
Fig 2. Kaplan-Meier curve depicts the rate of catheter-associated
upper extremity deep venous thrombosis (DVT) resolution by
follow-up duplex ultrasound imaging.bus resolution in these patients was observed in 24 of 43
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75% resolved by 100 days (range, 1-914 days) after catheter
removal 48 hours of diagnosis. When the catheter was
removed48 hours after diagnosis, the thrombus resolved
in 16 of 34 patients (47%) at an average of 94 days (range,
5-438 days) from catheter removal (P  .4962; Fig 3, A
and B).
Effect of anticoagulation. Anticoagulation was used
in 62 of the 101 patients (62%) in the study. The ordering
physician chose the type of anticoagulation. Most patients
received unfractionated heparin, with eventual transition to
warfarin. Thrombus resolution was documented in 24 of
62 patients (38%) when the patient was anticoagulated.
Thrombus resolved in 22 of 39 patients (56.4%) who were
not anticoagulated for CAUEDVT (P  .1021). After risk
factor analysis was factored into the anticoagulated vs the
Fig 3. A,Kaplan-Meier curve depicts the rate of catheter-associated
upper extremity deep venous thrombosis (DVT) resolution with
and without catheter removal. B, Kaplan-Meier curve depicts the
effect of early catheter removal on the resolution of catheter-
associated upper extremity DVT.non anticoagulated group, we found the two groups weresimilar in risk, and there were no significant differences
between them.
Resolution was seen in 19 of 41 patients (46%) when
anticoagulation was instituted 48 hours of diagnosis vs
resolution in five of 21 (23.8%) when anticoagulation was
started 48 hours after diagnosis (P  .1043). Anticoag-
ulation also was not protective against progression of
CAUEDVT, which was found in 12 patients on follow-up
DU scanning. Eight had been treated with anticoagulation
for the CAUEDVT, and five of the 12 patients underwent
catheter removal during follow-up. Anticoagulation was
stopped for bleeding complications in 16 of the 62 patients
(25.8%) who were treated with anticoagulation.
Influence of combined catheter removal and
anticoagulation. Catheters were removed in 77 of 101
cases (77%) of CAUEDVT, anticoagulation was used in 62
(62%), and both catheter removal and anticoagulation were
used in 49 (49%). In multivariate analysis, only catheter
removal predicted likelihood of thrombus resolution (OR,
3.25; 95% CI, 1.16-9.09; P  .025).
Influence of patient characteristics. Risk factors in
patients with CAUEDVT included malignancy in 34%,
recent surgery or trauma in 34%, end-stage renal disease in
33%, congestive heart failure in 11%, known hypercoagula-
ble state in 9%, and diabetes mellitus in 8%. In multivariate
analysis, only end-stage renal disease significantly predicted
failure to resolve thrombus (95% CI, 1.6-13.1, P  .004).
Outcome of new-site catheter placement for
CAUEDVT. In 11 patients with a CAUEDVT, the cath-
eter was removed, and a new catheter was placed at a new
site presumably not involved with thrombus. This sequence
occurred twice in three of the patients where the second
catheter also became involved with thrombus. Overall
therefore, there were 14 instances in which a new catheter
was placed in a patient with CAUEDVT at a site presum-
ably not previously involved with thrombus. A new
CAUEDVT developed in association with the new catheter
in 12 of the 14 (86%) subsequent catheter placements with
all but one of these new CAUEDVTs developing10 days
of placement of the new catheter. Three of these 12 patients
were receiving anticoagulation therapy when the old cath-
eter was removed, and a new catheter was placed in a
different anatomic site.
Pulmonary embolism. Five of the 101 patients were
diagnosed with PE, none of which were fatal, and four
underwent anticoagulation. The patient who did not un-
dergo anticoagulation also had a negative result on a lower
extremity venous DU examination. In three of the five
patients with a diagnosed PE, DU imaging also showed a
LEDVT. In the remaining patient, the lower extremity
veins were not assessed for DVT.
DISCUSSION
This study has some weaknesses, including the small
number of patients, retrospective design, and variability of
follow-up observations. There was no accepted protocol to
monitor patients with newly diagnosed UEDVTs with DU
examinations. Most of the follow-up DU examinations in
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or in planning the placement for a new catheter. There is
therefore a selection bias to patients with changes in symp-
toms or patients requiring continued central venous access.
Nevertheless, the results are intriguing in that they confirm
but also challenge some traditional thoughts about
CAUEDVT and its management while providing some
new follow-up imaging data on CAUEDVT.
CAUEDVT is a common problem. DVT is obviously a
very common problem as well, and UEDVT accounts for 1%
to 4% of all cases ofDVT,5 with central venous catheters by far
the most common risk factor for UEDVT. In four studies,
central venous catheters were associated with 65%, 51%, 55%,
and 60% of cases of UEDVT.1-4 CAUEDVT has been docu-
mented in 33% of 208 consecutive central venous catheters
placed in intensive care unit patients.6 In our study as well, a
high proportion of patients with UEDVT had CAUEDVT.
Although CAUEDVT is frequent, there is remarkably
little follow-up imaging information available, and man-
agement is not standardized. Only two previous studies
have provided any follow-up imaging information at all
after the diagnosis of UEDVT, and not all patients in those
studies had CAUEDVT. One author evaluated 53 patients
with a diagnosis of UEDVT, and only six were CAUEDVTs.
All patients in this study were anticoagulated for 3 months.
With follow-up DU examinations every 6 months for 5
years, recurrent UEDVT was documented at 1, 2, and 5
years as 2.0%, 4.2%, and 7.7%, respectively.7
A study of subclavian vein stenosis in patients undergo-
ing hemodialysis used venography to document a recanali-
zation rate of 45.4% at 3 months after catheter removal.8
There was a trend toward increased recanalization when
catheters had been in place29 days. Therefore, although
the number of patients and the information provided here
is not ideal, it considerably exceeds previously available data
for patients with CAUEDVT monitored with imaging
studies. In this series of 101 cases of CAUEDVT with
available follow-up DU examinations, we observed an abso-
lute resolution rate of 46% when the average was 100 days to
the follow-up DU examination (range, 1-914 days). Only
removal of the catheter seemed to affect DU-documented
complete resolution of CAUEDVT.
Of interest is that anticoagulation did not appear to
affect the rate of resolution or decrease progression of
CAUEDVT and was associated with a significant incidence
(about 25%) of bleeding complications. Progression of
CAUEDVT occurred despite anticoagulation in eight of
the 12 patients with documented progression of catheter-
associated thrombus; however, seven of these patients with
progression of catheter-associated thrombus were already
at high risk for progression because of comorbidities, in-
cluding malignancy, coagulopathy, and lack of catheter
removal. Anticoagulation was stopped in 16 of the 62
patients because of bleeding complications. This high rate
of bleeding complications may be because those who re-
quire central venous access are higher-acuity patients and
perhaps are more prone to a bleeding diathesis than the
usual patient with lower extremity DVT.In addition, documented PE without associated lower
extremity DVT was unusual in this patient group (2%), and
none were fatal. Although screening studies for PE were
not performed, the low rate of confirmed PE indicates that
short-term clinically important PE is unlikely in patients
with isolated CAUEDVT. A low rate of PE in patients with
UEDVT has also been recently documented in a commu-
nity hospital setting.9 The low rate of PE in patients with
isolated CAUEDVT, combined with an apparent lack of
benefit of anticoagulation on the thrombus itself and the
associated bleeding complications of anticoagulation in the
patients with CAUEDVT, must lead one to question,
despite recommendations of the American College of
Chest Physicians,10 the utility of anticoagulation in patients
with isolated CAUEDVT who do not have an additional
indication for anticoagulation.
It did not appear that prompt removal of the cat-
heter resulted in dramatically improved resolution of
CAUEDVT. What mattered was removal of the catheter,
not when it was removed. In addition in this study, removal
of central venous catheters associated with thrombus and
subsequent placement of a new central venous access at a
new site previously uninvolved with thrombus almost al-
ways resulted in new CAUEDVT. The implication is that it
may be best in a patient with CAUEDVT to leave the
catheter in place as long as it is needed, functions, and is not
infected and then remove the catheter once it is no longer
required for therapy. Such an algorithm will limit the
development of UEDVT and may not adversely affect
resolution of the initial CAUEDVT.
CONCLUSIONS
Additional studies are needed to confirm the current
observations. Nevertheless, if the observations presented
here are confirmed, it may be possible to greatly simplify the
management of catheter-associated upper extremity deep
venous thrombosis by eliminating the common practices of
anticoagulation and new-site catheter placements in pa-
tients with catheter-associated UEDVT.
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The authors report a retrospective study undertaken in an
effort to characterize the natural history of catheter-associated
upper extremity deep venous thrombosis (CAUEDVT). The find-
ings, although interesting and intriguing, should be interpreted
cautiously. The data indicate that 46% of the patients with
CAUEDVT had documented resolution of thrombus on follow-up
studies. Life-table analysis projected resolution in 73% of patients
at 24 months. The incidence of resolution was significantly de-
creased when the catheter was not removed, whereas anticoagula-
tion did not affect the rate of resolution.
These data, however, may have been influenced by patient
selection. The study was limited to symptomatic patients with
follow-up ultrasound evaluation. Results cannot be extrapolated to
patients with asymptomatic CAUEDVT. The acuity of thrombus
was presumed from clinical presentation alone; characteristics of
the ultrasound examination were not used to distinguish acute and
chronic thrombus. The number of follow-up studies per patient
was small (1.76) and may have been selectively obtained based on
the recurrence of symptoms or the need for additional access.
There was no formal follow-up protocol, and the time-frame for
follow-up studies varied from 1 day to 7.9 years, with one to 10
studies per patient. As a result, the data presented in the life-table
format may not accurately reflect the course of thrombus resolu-
tion.
On the basis of their identified incidence of pulmonary embo-
lism (5%), bleeding complications on anticoagulation (25.8%), and
the observation that anticoagulation did not influence thrombus
resolution, the authors have questioned the utility of anticoagula-
tion in patients with CAUEDVT. Although the recommendations
of this study challenge current conventions,1 the following should
be considered. Anticoagulation was not managed in a standardized
fashion, with identified therapeutic targets; the frequency of ther-
apeutic outliers was not reported. The incidence of bleeding in this
study was high (25.8%) compared with other reported studies.
Outcomes from the REITE initiative (Registro Informatizado de
la Enfermedad TromboEmbolica [Computerized Registry of
Patients With Venous Thromboembolism], a registry of 17,368
consecutive patients with objectively confirmed, symptomaticpatients with DVT.2 Of the 512 patients with upper extremity
DVT, the incidence of major bleeding was only 2.1%; those with
CAUEDVT had a 3.1% incidence of major bleeding.3
The exact incidence of pulmonary embolism associated with
CAUEDVT in this series is uncertain because some patients also
had lower extremity DVT. The reported incidence varies. Monreal
et al4 reported a 16% incidence of pulmonary embolism identified
by V/Q scan 24 hours of the CAUEDVT diagnosis. Munoz et
al3 reported that 9% of patients with armDVT had a clinically overt
pulmonary embolism on presentation; but only a 1.8% recurrence
after 3 months of follow-up. Other series have reported a fre-
quency of 15% to 50% in patients with CAUEDVT.5
The study is challenging and arrives at some intriguing con-
clusions. On the basis of the variability of reported data and
protocols, however, I suspect that these findings should provide
the impetus for further prospective evaluations of the natural
history and management of CAUEDVT rather than drive thera-
peutic change.
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